Bollard Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2K | Hold |
68
| – | – | ﹤0.01% | 297 |
|
|
2026
Q1 | $2K | Sell |
68
-56
| -45% | -$1.49K | ﹤0.01% | 295 |
|
|
2025
Q4 | $3K | Buy |
124
+2
| +2% | +$50 | ﹤0.01% | 278 |
|
|
2025
Q3 | $3K | Buy |
122
+2
| +2% | +$49 | ﹤0.01% | 255 |
|
|
2025
Q2 | $3K | Sell |
120
-29,462
| -100% | -$687K | ﹤0.01% | 276 |
|
|
2025
Q1 | $750K | Sell |
29,582
-2,096
| -7% | -$54.8K | 0.02% | 118 |
|
|
2024
Q4 | $840K | Sell |
31,678
-1,671
| -5% | -$45.3K | 0.02% | 114 |
|
|
2024
Q3 | $965K | Sell |
33,349
-242
| -0.7% | -$7.06K | 0.03% | 120 |
|
|
2024
Q2 | $940K | Sell |
33,591
-42,349
| -56% | -$1.17M | 0.03% | 113 |
|
|
2024
Q1 | $2.11M | Buy |
75,940
+851
| +1% | +$23.6K | 0.06% | 81 |
|
|
2023
Q4 | $2.16M | Sell |
75,089
-3,640
| -5% | -$110K | 0.08% | 77 |
|
|
2023
Q3 | $2.61M | Buy |
78,729
+236
| +0.3% | +$8.35K | 0.1% | 71 |
|
|
2023
Q2 | $2.88M | Buy |
78,493
+468
| +0.6% | +$18.2K | 0.1% | 76 |
|
|
2023
Q1 | $3.18M | Buy |
78,025
+202
| +0.3% | +$8.72K | 0.12% | 72 |
|
|
2022
Q4 | $3.99M | Sell |
77,823
-2,619
| -3% | -$126K | 0.15% | 69 |
|
|
2022
Q3 | $3.52M | Sell |
80,442
-636
| -0.8% | -$30.9K | 0.15% | 73 |
|
|
2022
Q2 | $4.25M | Buy |
81,078
+171
| +0.2% | +$8.71K | 0.17% | 71 |
|
|
2022
Q1 | $4.19M | Buy |
80,907
+193
| +0.2% | +$10K | 0.13% | 79 |
|
|
2021
Q4 | $4.77M | Buy |
80,714
+164
| +0.2% | +$8.13K | 0.15% | 80 |
|
|
2021
Q3 | $3.46M | Buy |
80,550
+200
| +0.2% | +$8.86K | 0.11% | 87 |
|
|
2021
Q2 | $3.15M | Buy |
80,350
+237
| +0.3% | +$9.22K | 0.1% | 89 |
|
|
2021
Q1 | $2.9M | Buy |
80,113
+16
| +0% | +$568 | 0.1% | 87 |
|
|
2020
Q4 | $2.95M | Sell |
80,097
-5,362
| -6% | -$197K | 0.11% | 81 |
|
|
2020
Q3 | $2.98M | Sell |
85,459
-805
| -0.9% | -$28.2K | 0.11% | 83 |
|
|
2020
Q2 | $2.68M | Buy |
86,264
+5,833
| +7% | +$198K | 0.11% | 83 |
|
|
2020
Q1 | $2.49M | Sell |
80,431
-8,541
| -10% | -$291K | 0.11% | 79 |
|
|
2019
Q4 | $3.31M | Buy |
88,972
+600
| +0.7% | +$21.4K | 0.11% | 89 |
|
|
2019
Q3 | $3.01M | Buy |
88,372
+644
| +0.7% | +$23.4K | 0.11% | 90 |
|
|
2019
Q2 | $3.61M | Buy |
87,728
+553
| +0.6% | +$22K | 0.12% | 90 |
|
|
2019
Q1 | $3.51M | Buy |
87,175
+545
| +0.6% | +$21.8K | 0.13% | 90 |
|
|
2018
Q4 | $3.59M | Buy |
86,630
+1,323
| +2% | +$54.9K | 0.16% | 69 |
|
|
2018
Q3 | $3.57M | Buy |
85,307
+571
| +0.7% | +$22K | 0.14% | 79 |
|
|
2018
Q2 | $2.92M | Buy |
84,736
+647
| +0.8% | +$22.1K | 0.13% | 83 |
|
|
2018
Q1 | $2.83M | Buy |
84,089
+639
| +0.8% | +$22K | 0.14% | 87 |
|
|
2017
Q4 | $2.87M | Buy |
83,450
+597
| +0.7% | +$20.4K | 0.14% | 79 |
|
|
2017
Q3 | $2.81M | Buy |
82,853
+3,166
| +4% | +$102K | 0.15% | 83 |
|
|
2017
Q2 | $2.54M | Buy |
79,687
+1,359
| +2% | +$42.9K | 0.14% | 92 |
|
|
2017
Q1 | $2.54M | Buy |
78,328
+4,178
| +6% | +$132K | 0.15% | 88 |
|
|
2016
Q4 | $2.29M | Buy |
74,150
+1,867
| +3% | +$57K | 0.15% | 91 |
|
|
2016
Q3 | $2.32M | Buy |
72,283
+3,352
| +5% | +$112K | 0.15% | 86 |
|
|
2016
Q2 | $2.3M | Buy |
68,931
+462
| +0.7% | +$14.7K | 0.16% | 80 |
|
|
2016
Q1 | $1.93M | Buy |
68,469
+526
| +0.8% | +$15K | 0.16% | 85 |
|
|
2015
Q4 | $2.08M | Buy |
67,943
+444
| +0.7% | +$14K | 0.17% | 81 |
|
|
2015
Q3 | $2.01M | Buy |
67,499
+533
| +0.8% | +$17.1K | 0.17% | 91 |
|
|
2015
Q2 | $2.13M | Buy |
66,966
+490
| +0.7% | +$16K | 0.16% | 91 |
|
|
2015
Q1 | $2.19M | Buy |
66,476
+485
| +0.7% | +$15.4K | 0.16% | 88 |
|
|
2014
Q4 | $1.95M | Buy |
65,991
+942
| +1% | +$27K | 0.17% | 86 |
|
|
2014
Q3 | $1.82M | Buy |
65,049
+387
| +0.6% | +$10.9K | 0.17% | 92 |
|
|
2014
Q2 | $1.82M | Buy |
64,662
+93
| +0.1% | +$2.65K | 0.18% | 87 |
|
|
2014
Q1 | $1.97M | Buy |
64,569
+2,174
| +3% | +$64.8K | 0.2% | 68 |
|
|
2013
Q4 | $1.81M | Sell |
62,395
-36,826
| -37% | -$1.07M | 0.2% | 67 |
|
|
2013
Q3 | $2.7M | Buy |
99,221
+35,115
| +55% | +$955K | 0.32% | 51 |
|
|
2013
Q2 | $1.7M | Buy |
+64,106
| New | +$1.77M | 0.33% | 55 |
|
Other funds holding PFE
Bollard Group's PFE Position: Q2 2026 in Review
Bollard Group held its Pfizer (PFE) position steady in Q2 2026 at 68 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #297.
Bollard Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.77M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bollard Group held 68 shares of Pfizer worth $2K as of Q2 2026.
- Bollard Group left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up ﹤0.01% of Bollard Group's portfolio in Q2 2026, its #297 holding.
- Bollard Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Bollard Group's Pfizer position peaked at $4.77M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.